84
Participants
Start Date
December 13, 2013
Primary Completion Date
September 1, 2016
Study Completion Date
October 31, 2018
talazoparib
Memorial Sloan Kettering Evelyn H. Lauder Breast Center, New York
Memorial Sloan-Kettering Cancer Center, New York
Memorial Sloan Kettering Rockville Centre, Rockville Centre
Helios Klinikum Berlin-Buch, Berlin
Complejo Hospitalario Universitario A Coruna, A Coruña
g.SUND Gynaekologie Kompetenzzentrum Stralsund, Stralsund
Sidney Kimmel Comprehensive Cancer Center (SKCCC) at Johns Hopkins, Green Spring Station, Lutherville
Sidney Kimmel Comprehensive Cancer Center (SKCCC) at Johns Hopkins, Baltimore
Anne Arundel Medical Center (AAMC), Annapolis Oncology and Hematology, Annapolis
Anne Arundel Medical Center (AAMC), Research Pharmacy, Annapolis
Anne Arundel Medical Center (AAMC), Annapolis
Complejo Hospitalario de Jaen, Jaén
Universitaetsklinikum Schleswig-Holstein, Kiel
Hospital General Universitario Gregorio Maranon, Madrid
MD Anderson Cancer Center International Espana, Madrid
Hospital Clinico San Carlos, Madrid
Memorial Cancer Institute at Memorial Regional Hospital, Hollywood
Memorial Regional Hospital, Hollywood
Memorial Breast Cancer Center at Memorial Hospital West, Pembroke Pines
Memorial Cancer Institute at Memorial Hospital West, Pembroke Pines
Memorial Hospital West, Pembroke Pines
University of Miami Hospital & Clinics, Miami
Sylvester at Plantation, Plantation
Sylvester at Deerfield Beach, Deerfield Beach
CHU Bretonneau Centre Henry Kaplan, Tours
Tennessee Oncology, PLLC, Nashville
The Sarah Cannon Research Institute, Nashville
University of Tennessee Medical Center, Knoxville
University Hospital Duesseldorf, Düsseldorf
Hospital Universitario Virgen Macarena, Seville
Kliniken Essen Mitte Klinik fuer Gynaekologie und Gynaekologische Onkologie, Essen
Indiana University Health Melvin and Bren Simon Cancer Center, Indianapolis
Investigational Drug Services, Indianapolis
IU Health University Hospital, Indianapolis
Sidney & Lois Eskenazi Hospital, Indianapolis
Springmill Medical Clinic, Indianapolis
Hospital Universitario Miguel Servet, Zaragoza
Klinikum Mutterhaus Der Borromaeerinnen Ggmbh, Trier
Centre Oscar Lambret, Lille Cédex
Centre Leon Berard, Lyon
Universitaets-Frauenklinik, Tübingen
IOZ Muenchen - lnerdisziplinaeres Onkologisches Zentrum, Munich
University of Munich (LMU) Grosshadern Hospital, Munich
Klinikum rechts der Isar der TU Muenchen, Munich
TRIO-US Central Administration, Los Angeles
Torrance Health Association, DBA Torrance Memorial Physician Network/Cancer Care Associates, Redondo Beach
UCLA Hematology-Oncology, Santa Monica
Universitaetsklinikum Erlangen, Erlangen
UCLA Hematology Oncology- Porter Ranch, Porter Ranch
University of California, San Francisco: Helen Diller Comprehensive Cancer Center, San Francisco
Stanford Women's Cancer Center, Palo Alto
Stanford Cancer Institute, Stanford
Stanford Hospital and Clinics, Stanford
Marin Cancer Care, Inc., Greenbrae
UCLA West Medical Pharmacy Attn: Steven L. Wong, PharmD, Los Angeles
UCLA West Medical Pharmacy, Attn: Steven L. Wong, Pharm.D., Los Angeles
ICRC, Indianapolis
The University of Texas MD Anderson Cancer Center, Houston
Institut Paoli Calmettes, Marseille
Hopital Prive du Confluent, Nantes BP 20215
Hopitaux Universitaires de Strasbourg - Hopital Civil, Strasbourg
Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse
University Hospital Carl Gustav Carus, Dresden
Hospital Universitari Vall d'Hebron, Barcelona
Hospital Universitario San Juan de Alicante, Sant Joan d'Alacant
Cambridge University Hospital NHS Foundation Trust, Cambridge
Sarah Cannon Research Institute UK, London
Lancashire Teaching Hospitals NHS Foundation Trust, Preston
The Royal Marsden NHS Foundation Trust, London
The Christie NHS Foundation Trust, Manchester
The Royal Marsden NHS Foundation Trust, Sutton
Lead Sponsor
Collaborators (1)
Myriad Genetic Laboratories, Inc.
INDUSTRY
Medivation, Inc.
INDUSTRY
Pfizer
INDUSTRY